These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33976004)

  • 1. Implication of nanotechnology-based approaches to combat SARS-CoV-2 infection.
    Heidari M; Salmanpour M; Tamaddon AM
    Indian J Pharmacol; 2021; 53(1):78-79. PubMed ID: 33976004
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of nanoparticle-delivery systems for antiviral agents: A review.
    Delshadi R; Bahrami A; McClements DJ; Moore MD; Williams L
    J Control Release; 2021 Mar; 331():30-44. PubMed ID: 33450319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach.
    Abd El Hadi SR; Zien El-Deen EE; Bahaa MM; Sadakah AA; Yassin HA
    Drug Des Devel Ther; 2021; 15():3313-3330. PubMed ID: 34366663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
    Campos DMO; Fulco UL; de Oliveira CBS; Oliveira JIN
    J Evid Based Med; 2020 Nov; 13(4):255-260. PubMed ID: 33058394
    [No Abstract]   [Full Text] [Related]  

  • 5. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.
    Formiga FR; Leblanc R; de Souza Rebouças J; Farias LP; de Oliveira RN; Pena L
    J Control Release; 2021 Jan; 329():758-761. PubMed ID: 33038449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An EUA for bamlanivimab and etesevimab for COVID-19.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):49-50. PubMed ID: 33830966
    [No Abstract]   [Full Text] [Related]  

  • 7. Ensuring continued progress for development of COVID-19 therapeutics in children.
    Noel GJ; DeBiasi RL; Crandall W; Connor EM
    Pediatr Res; 2021 Dec; 90(6):1112-1114. PubMed ID: 33603214
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of chemical biology in the fight against SARS-CoV-2.
    Burslem GM
    Biochem J; 2021 Jan; 478(1):157-177. PubMed ID: 33439990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment.
    Witika BA; Makoni PA; Mweetwa LL; Ntemi PV; Chikukwa MTR; Matafwali SK; Mwila C; Mudenda S; Katandula J; Walker RB
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
    Saify Nabiabad H; Amini M; Demirdas S
    Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New SARS-CoV-2 Variants Challenge Vaccines Protection.
    Soriano V; Fernández-Montero JV
    AIDS Rev; 2021 Feb; 23(1):57-58. PubMed ID: 33750742
    [No Abstract]   [Full Text] [Related]  

  • 12. Alopecia areata in a patient with SARS-Cov-2 infection.
    Sgubbi P; Savoia F; Calderoni O; Longo R; Stinchi C; Tabanelli M
    Dermatol Ther; 2020 Nov; 33(6):e14295. PubMed ID: 32909635
    [No Abstract]   [Full Text] [Related]  

  • 13. CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection.
    Pourani MR; Nekooghadam SM; Youssefian L; Vahidnezhad H; Abdollahimajd F
    Dermatol Ther; 2020 Nov; 33(6):e14449. PubMed ID: 33098610
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.
    Goudarzi S; Dehghani Firouzabadi F; Dehghani Firouzabadi M; Rezaei N
    Dermatol Ther; 2020 Nov; 33(6):e14266. PubMed ID: 32882081
    [No Abstract]   [Full Text] [Related]  

  • 15. Onychomadesis following COVID-19 infection: Is there a relationship?
    Senturk N; Ozdemir H
    Dermatol Ther; 2020 Nov; 33(6):e14309. PubMed ID: 32935910
    [No Abstract]   [Full Text] [Related]  

  • 16. Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials.
    Pandey A; Nikam AN; Mutalik SP; Fernandes G; Shreya AB; Padya BS; Raychaudhuri R; Kulkarni S; Prassl R; Subramanian S; Korde A; Mutalik S
    ACS Biomater Sci Eng; 2021 Jan; 7(1):31-54. PubMed ID: 33371667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
    Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
    Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.
    Rosenke K; Hansen F; Schwarz B; Feldmann F; Haddock E; Rosenke R; Barbian K; Meade-White K; Okumura A; Leventhal S; Hawman DW; Ricotta E; Bosio CM; Martens C; Saturday G; Feldmann H; Jarvis MA
    Nat Commun; 2021 Apr; 12(1):2295. PubMed ID: 33863887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro.
    Ohashi H; Wang F; Stappenbeck F; Tsuchimoto K; Kobayashi C; Saso W; Kataoka M; Yamasaki M; Kuramochi K; Muramatsu M; Suzuki T; Sureau C; Takeda M; Wakita T; Parhami F; Watashi K
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An EUA for sotrovimab for treatment of COVID-19.
    Med Lett Drugs Ther; 2021 Jun; 63(1627):97-xx98. PubMed ID: 34181630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.